Acta Med. 2018, 61: 74-77
https://doi.org/10.14712/18059694.2018.56
Cerebral Infarction in Young Marijuana Smokers – Case Reports
References
1. Arch Gen Psychiatry 2007; 64: 495–502.
< AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: A population-based study of hospitalized patients. https://doi.org/10.1001/archpsyc.64.4.495>
2. J Neurol Sci 2016; 364: 191–6.
< K, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. https://doi.org/10.1016/j.jns.2016.01.066>
3. Aust N Z J Public Health 2016; 40: 226–30.
< D, McKetin R, Cherbuin N, Anstey KJ. Heavy cannabis users at elevated risk of stroke: evidence from a general population survey. https://doi.org/10.1111/1753-6405.12477>
4. Int J Clin Pract 2008; 62: 308–13.
< P, Liu T, Papaioannides D, Li G, Goudevenos JA. Atrial fibrillation and marijuana smoking. https://doi.org/10.1111/j.1742-1241.2007.01505.x>
5. Circulation 2001; 103: 2805–9.
< MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. https://doi.org/10.1161/01.CIR.103.23.2805>
6. Postgrad Med J 2009; 85: 80–3.
< BR, Treadwell SD. Cannabis and stroke: is there a link? https://doi.org/10.1136/pgmj.2008.070425>
7. Lancet Neurol 2012; 11: 906–17.
< A. Reversible cerebral vasoconstriction syndrome. https://doi.org/10.1016/S1474-4422(12)70135-7>
8. Cesk Slov Neurol N 2017; 80(6): 708–10.
L, Smetanová L, Herzig R, Vališ M. Reversible cerebral vasoconstriction syndrome.
9. AJNR Am J Neuroradiol 2015; 36: 1392–9.
< TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 1: Epidemiology, pathogenesis, and clinical course. https://doi.org/10.3174/ajnr.A4214>
<PubMed>
10. Mayo Clin Proc 1984; 59: 17–20.
< PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. https://doi.org/10.1016/S0025-6196(12)60336-X>
11. Drug Alcohol Depend 2009; 105: 24–32.
< RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. Extended urinary delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. https://doi.org/10.1016/j.drugalcdep.2009.05.027>
<PubMed>